6 Comments

CureVac makes a vague announcement about disappointing efficacy, but with key information missing.

https://www.washingtonpost.com/health/2021/06/16/curevac-vaccine-how-effective/

You are actually an expert on pharma communications ... why would you say, "Our vaccine is not that great, but maybe it's because of variants" and *nothing else*?

Expand full comment

Thanks, your comments on the possible mechanisms of vaccine-emergent myocarditis (if in fact that's what we're seeing) were informative. It will be interesting to see what comes out of Friday's meeting.

You're right that myocarditis is a manageable condition in the population that's currently the focus of concern. My understanding, though, is that it is often more serious in young children, resulting in death or the development of chronic conditions in a substantial number of cases. My hope is that elucidating the mechanism of the cases currently being examined will give us some idea of how concerned we should be about it occurring in younger age groups.

Did you happen to see or read about last week's VRBPAC meeting on pediatric vaccinations? The members were kind of all over the place on the topic of vaccinating kids under 12. A notable skeptic was Cody Meissner of Tufts, who previously had abstained from voting on the original Pfizer EUA because it included 16- and 17-year-olds. Weirdly, Meissner also was (is?) a supporter of the Great Barrington Declaration. He and at least one other member suggested that COVID should no longer be considered and emergency, or shouldn't be considered an emergency for children, both suggestions that frankly struck me as a surreal.

Expand full comment